For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260408:nRSH4630Za&default-theme=true
RNS Number : 4630Z Fevertree Drinks PLC 08 April 2026
8(th) April 2026
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Transaction in Own Shares
Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has,
in accordance with the authority granted by shareholders at its 2025 Annual
General Meeting held on 5(th) June, purchased the following number of ordinary
shares of £0.0025 each in the Company (the "Ordinary Shares") through the
Company's broker, Investec Bank plc ("Investec") in the period from 30(th)
March 2026 to 2(nd) April 2026.
Date Venue Volume-weighted average price (p) Aggregated volume Lowest price per share (p) Highest price per share (p)
30 March 2026 XLON 773.9625 15,477 762.0000 786.0000
31 March 2026 XLON 769.7277 15,969 760.0000 786.0000
01 April 2026 XLON 768.0082 29,868 761.0000 780.0000
01 April 2026 AIMX 770.0000 16,062 770.0000 770.0000
02 April 2026 XLON 762.4542 29,336 755.0000 768.0000
02 April 2026 AIMX 766.0000 16,236 766.0000 766.0000
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (which forms part of domestic UK law by virtue of the
European Union (Withdrawal) Act 2018, as amended), a full breakdown of the
individual trades made by Investec on behalf of the Company as part of the
share buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/4630Z_1-2026-4-7.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/4630Z_1-2026-4-7.pdf)
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
For further information please contact:
Investor queries
Steve Nightingale, Director of Investor Relations I
steve.nightingale@fever-tree.com I +44 (0)7951 849564
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSKDLBBQZLFBBF
Copyright 2019 Regulatory News Service, all rights reserved